Feldman AM, McNamara D., Myocarditis. N Engl J Med. 2000; 343: 1388-1398.
Yajima T, Knowlton KU., Viral myocarditis: from the perspective of the virus. Circulation. 2009; 119: 2615-2624.
Ukena C, Kindermann M, Mahfoud F, et al. Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis. Clin Res Cardiol. 2014; 103: 743-751.
Molina KM, Garcia X, Denfield SW, et al. Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatr Cardiol. 2013; 34: 390-397.
Smith SC, Ladenson JH, Mason JW, Jaffe AS., Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation. 1997; 95: 163-168.
Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol. 2012; 59: 779-792.
Anderson BR, Silver ES, Richmond ME, Liberman L., Usefulness of arrhythmias as predictors of death and resource utilization in children with myocarditis. Am J Cardiol. 2014; 114: 1400-1405.
Al-Biltagi M, Issa M, Hagar HA, Abdel-Hafez M, Aziz NA., Circulating cardiac troponins levels and cardiac dysfunction in children with acute and fulminant viral myocarditis. Acta Pediatr. 2010; 99: 1510-1516.
Freixa X, Sionis A, Castel A, et al. Low troponin-I levels on admission are associated with worse prognosis in patients with fulminant myocarditis. Transplant Proc. 2009; 41: 2234-2236.
